Increased human scleral permeability with prostaglandin exposure

Area of Science:

• Ophthalmology
• Biochemistry
• Cell Biology

Background:

• The sclera, a key ocular tissue, plays a role in drug delivery to the eye.
• Understanding scleral permeability is crucial for developing effective ocular therapies.
• Prostaglandins (PGs) are known modulators of tissue permeability.

Purpose of the Study:

• To investigate the in vitro effect of various prostaglandins (PGs) on human scleral permeability.
• To determine the dose- and time-dependent effects of PGs on scleral tissue.
• To explore the relationship between PG exposure and matrix metalloproteinase (MMP) expression in the sclera.

Main Methods:

• Human scleral tissues were organ-cultured and exposed to different concentrations of PGF(2alpha), 17-phenyltrinor PGF(2alpha), and PhXA85.
• Scleral permeability was assessed using rhodamine-dextran polymers of varying molecular weights in an Ussing apparatus.
• Matrix metalloproteinase (MMP-1, -2, -3) concentrations in the culture media were measured via ELISA.

Main Results:

• PG exposure significantly increased human scleral permeability in a dose- and time-dependent manner.
• PhXA85 demonstrated the most pronounced increase in permeability, followed by PGF(2alpha) and 17-phenyltrinor PGF(2alpha).
• PG treatment led to a significant, dose- and time-dependent increase in MMP-2 and MMP-3 expression, with a lesser effect on MMP-1.

Conclusions:

• Various prostaglandins, including PhXA85, increase human scleral permeability in vitro.
• The observed increase in scleral permeability is associated with elevated expression of matrix metalloproteinases (MMPs).
• These findings have implications for drug delivery strategies targeting the eye.